Stock Events

Stock Events

Myomo 

€0.75
0
+€0.06+8.59% Monday 06:03

Statistics

Day High
0.75
Day Low
0.75
52W High
4.45
52W Low
0.57
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.1
-0.09
-0.08
-0.07
Expected EPS
-0.09728646
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0M61.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ekso Bionics Common Stock
EKSO
Mkt Cap42.05M
Ekso Bionics designs and manufactures powered exoskeletons which can be used for rehabilitation and mobility, directly competing with Myomo's mobility enhancement devices.
Resmed
RMD
Mkt Cap29.87B
ResMed is known for its products in the sleep and respiratory markets but also offers devices that can improve quality of life, indirectly competing with Myomo's focus on enhancing mobility.
Hologic
HOLX
Mkt Cap16.97B
Hologic, primarily focused on women's health, also develops medical devices that can compete indirectly with Myomo by offering diagnostic and treatment solutions in overlapping healthcare markets.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew specializes in orthopedics, including robotics and digital solutions for surgery, which can indirectly compete with Myomo's orthotic devices by offering alternative treatments and rehabilitation methods.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, including products for joint reconstruction which can indirectly compete with Myomo's solutions for mobility and rehabilitation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc offers a wide range of medical devices and therapies, including those for spinal and musculoskeletal conditions, indirectly competing with Myomo's assistive technologies.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation specializes in medical and surgical equipment, including neurotechnology and spine products, which can indirectly compete with Myomo's focus on enhancing mobility through technology.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic devices, indirectly competing with Myomo by offering alternative treatments for mobility impairments.

About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Mr. Paul R. Gudonis
Employees
184
Country
United States
ISIN
US62857J2015

Listings

MU
DE
0M61.MU
STU
DE
0M61.STU
F
DE
0M61.F
XASE
US
MYO

0 Comments

Share your thoughts

FAQ

What is Myomo stock price today?▼
The current price of 0M61.MU is €0.75 EUR — it has increased by +8.59% in the past 24 hours. Watch Myomo stock price performance more closely on the chart.
What is Myomo stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Myomo stocks are traded under the ticker 0M61.MU.
Is Myomo stock price growing?▼
0M61.MU stock has risen by +6.88% compared to the previous week, the month change is a +29.74% rise, over the last year Myomo has showed a -82.28% decrease.
When is the next Myomo earnings date?▼
Myomo is going to release the next earnings report on May 07, 2026.
What were Myomo earnings last quarter?▼
0M61.MU earnings for the last quarter are -0.08 EUR per share, whereas the estimation was -0.07 EUR resulting in a -4.65% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Myomo have?▼
As of May 06, 2026, the company has 184 employees.
In which sector is Myomo located?▼
Myomo operates in the Health & Wellness sector.
When did Myomo complete a stock split?▼
Myomo has not had any recent stock splits.
Where is Myomo headquartered?▼
Myomo is headquartered in Burlington, United States.